Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
CA 2174529 C · Owner: Walker, Mary W. · Inventors: Walker, Mary W.; Gerald, Christophe P. G.; Branchek, Theresa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides methods of modifying feeding behavior, including increasing or decreasing food consumption, e.g. in connection with treating obesity bulimia or anorexia. These methods involve administration of selective agonists or antagonists or the Y5 receptor. One such antagonist has the structure:, In addition, this invention provides an isolated nucleic acid molecule encoding a Y5 receptor an, isolated Y5 receptor protein, vectors comprising an isolated nucleic acid molecule encoding a Y5 receptor cells comprising such vectors, antibodies directed to the Y5 receptor, nucleic acid probes useful for detecting nucleic acid encoding Y5 receptors antisense, oligonucleotides …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 1, 1995 and granted February 11, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 1, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 1, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.